Journals / Journal of critical and intensive care (Online) / 2020 / Cilt: 11 - Sayı: 1

Cross-Reactivity to Meropenem and Ertapenem Without Imipenem

Pages
28–30
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, it has been discontinued after one dose due to appearing same adverse Besides, the lack of allergy history despite prior ceftazidime usage implies that the hypersensitivity reaction of the patient was unlikely related to the beta-lactam ring.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Carbapenems have a beta-lactam ring that might prone to cause hypersensitivity reactions.
📊
Key Findings & Data:A 75-years-old male patient was admitted to the surgical intensive care unit after whipple procedure for malignant neoplasm of the pancreas.
💡
Conclusion & Impact:However, it has been discontinued after one dose due to appearing same adverse Besides, the lack of allergy history despite prior ceftazidime usage implies that the hypersensitivity reaction of the patient was unlikely related to the beta-lactam ring.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Carbapenems have a beta-lactam ring that might prone to cause hypersensitivity reactions. We proposed that the clinical cross-reactivity between the individual carbapenems will develop independently from the betalactam ring in this case report. A 75-years-old male patient was admitted to the surgical intensive care unit after whipple procedure for malignant neoplasm of the pancreas. Meropenem and colistin was started because of increased oxygen demand. Most likely drug-induced generalized maculopapular skin rash developed on the first day of the antimicrobial effects with meropenem. therapy. Followed by discontinuation of meropenem, imipenem-cilastatin therapy was administered without any problem. Because of the increase in the existing infiltrate on the chest x-ray, ertapenem was added as a double-carbapenem strategy. However, it has been discontinued after one dose due to appearing same adverse Besides, the lack of allergy history despite prior ceftazidime usage implies that the hypersensitivity reaction of the patient was unlikely related to the beta-lactam ring.

🔖

Cite This Article

UZUN, O., EKINCI, P. B., YALCIN, A., DEMIRKAN, K., KARA, E. (2022). Cross-Reactivity to Meropenem and Ertapenem Without Imipenem. Journal of critical and intensive care (Online), Cilt: 11 - Sayı: 1, 28–30. https://ajindex.com/articles/562314

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bauer SL, Wall GC, Skoglund KJ, et al. Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin. J Allergy Clin Immunol 2004,;113:173–5. [CrossRef] 2. Saxon A, Adelman DC, Patel A, et al. Imipenem cross reactivity with penicillin in humans. J Allergy Clin Immunol 1988; 82:213–7. [CrossRef] 3. Lakhal K, Lortat-Jacob B, Neukirch C, et al. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem. Pharmacotherapy 2007;27:1334–8. [CrossRef] 4. Bauer SL, Wall GC, Skoglund KJ, et al. Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin. J Allergy Clin Immunol 2004;113:173– 5. [CrossRef] 5. Noguerado-Mellado B, Fernández CP, Pineda-Pineda R, et al. Crossreactivity between carbapenems: Two case reports. J Allergy Clin Immunol 2014;2:816–7. [CrossRef]